Lung cancer-associated T cell repertoire as potential biomarker for early detection of stage I lung cancer
Authors:
- Min LiMLMin Li
- Chengping HuCHChengping Hu
Open Access
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 162, 16-22
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81903020)
- China Postdoctoral Science Foundation (2019M652812)
This publication has 25 references indexed in Scilit:
- Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoireNature Genetics, 2017
- 3D: diversity, dynamics, differential testing – a proposed pipeline for analysis of next-generation sequencing T cell repertoire dataBMC Bioinformatics, 2017
- Risk assessment in relation to the detection of small pulmonary nodulesTranslational Lung Cancer Research, 2017
- Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after ImmunotherapyCancer Immunology Research, 2016
- Cancer treatment and survivorship statistics, 2016CA: A Cancer Journal for Clinicians, 2016
- Cancer statistics in China, 2015CA: A Cancer Journal for Clinicians, 2016
- Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanomaJournal for ImmunoTherapy of Cancer, 2015
- MiXCR: software for comprehensive adaptive immunity profilingNature Methods, 2015
- Liquid Biopsies: Genotyping Circulating Tumor DNAJournal of Clinical Oncology, 2014
- Oncology Meets Immunology: The Cancer-Immunity CycleImmunity, 2013